This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Explore a selection of our essential drug information below, or:
Identification
- Generic Name
- Racemethionine
- DrugBank Accession Number
- DB13972
- Background
A preparation of methionine that includes a mixture of D-methionine and L-methionine isomers.
- Type
- Small Molecule
- Groups
- Approved, Experimental
- Structure
Structure for Racemethionine (DB13972)
- Weight
- Average: 149.211
Monoisotopic: 149.051049291 - Chemical Formula
- C5H11NO2S
- Synonyms
- (+-)-Methionine
- DL-Methionine
- DL-Methioninum
- metionina
- Racemethionine
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Therapies
- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- No interactions found.
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image 24 Multivitamins + Minerals Racemethionine (25 mg) + Ascorbic acid (150 mg) + Beta carotene (10000 unit) + Biotin (25 mcg) + Calcium (130 mg) + Cholecalciferol (400 unit) + Choline bitartrate (25 mg) + Chromium (20 mcg) + Copper (1 mg) + Cyanocobalamin (25 mcg) + Ferrous fumarate (15 mg) + Folic acid (.8 mg) + Inositol (25 mg) + Magnesium (65 mg) + Manganese cation (2 mg) + Molybdenum (20 mcg) + Niacin (25 mg) + Calcium pantothenate (25 mg) + Potassium (15 mg) + Potassium Iodide (.1 mg) + Pyridoxine hydrochloride (25 mg) + Riboflavin (25 mg) + Selenium (20 mcg) + Thiamine hydrochloride (25 mg) + Vanadium (20 mcg) + Vitamin A palmitate (5000 unit) + Vitamin E (50 unit) + Zinc (10 mg) Tablet Oral Stanley Pharmaceuticals, A Division Of Vita Health Products Inc. 1997-04-30 2002-07-31 Canada 
50 Plus Racemethionine (20 mg) + Ascorbic acid (200 mg) + Biotin (20 mcg) + Choline bitartrate (20 mg) + Cyanocobalamin (20 mcg) + Folic acid (.2 mg) + Inositol (20 mg) + Niacin (20 mg) + Calcium pantothenate (20 mg) + Pyridoxine hydrochloride (20 mg) + Riboflavin (20 mg) + Thiamine hydrochloride (20 mg) + Vitamin A palmitate (10000 unit) + Vitamin D (400 unit) + Vitamin E (20 unit) Tablet Oral Quest Vitamins A Div Of Purity Life Health Products 1998-08-04 2001-07-06 Canada 8.5% Freamine III Racemethionine (450 mg / 100 mL) + Alanine (600 mg / 100 mL) + Arginine (810 mg / 100 mL) + Cysteine hydrochloride (13.9 mg / 100 mL) + Glycine (1.19 g / 100 mL) + Histidine (240 mg / 100 mL) + Isoleucine (590 mg / 100 mL) + Leucine (770 mg / 100 mL) + Lysine acetate (620 mg / 100 mL) + Phenylalanine (480 mg / 100 mL) + Proline (950 mg / 100 mL) + Serine (500 mg / 100 mL) + Threonine (340 mg / 100 mL) + Tryptophan (130 mg / 100 mL) + Valine (560 mg / 100 mL) Liquid Intravenous B. Braun Medical Inc. 1999-05-17 2012-04-16 Canada A/o-26 - Caplet Racemethionine (50 mg) + Beta carotene (7500 unit) + Calcium (75 mg) + Calcium ascorbate (250 mg) + Copper (1 mg) + DL-alpha tocopheryl acetate (100 unit) + Folic acid (.4 mg) + Manganese cation (2.5 mg) + Selenium (100 mcg) + Zinc (7.5 mg) Tablet Oral Enviro Tech International Canada 1996-12-19 1999-07-26 Canada Amino-cerv Racemethionine (0.83 %) + Cystine (0.354 %) + Inositol (0.83 %) + Sodium propionate (0.50 %) + Urea (8.34 %) Cream Vaginal Milex, A Coopersurgical Co. 1952-12-31 2007-07-26 Canada
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 73JWT2K6T3
- CAS number
- 59-51-8
- InChI Key
- FFEARJCKVFRZRR-UHFFFAOYSA-N
- InChI
- InChI=1S/C5H11NO2S/c1-9-3-2-4(6)5(7)8/h4H,2-3,6H2,1H3,(H,7,8)
- IUPAC Name
- 2-amino-4-(methylsulfanyl)butanoic acid
- SMILES
- CSCCC(N)C(O)=O
References
- General References
- Not Available
- External Links
- Human Metabolome Database
- HMDB0033951
- KEGG Drug
- D04983
- KEGG Compound
- C01733
- ChemSpider
- 853
- BindingDB
- 86195
- 9100
- ChEBI
- 16811
- ChEMBL
- CHEMBL274119
- Wikipedia
- Methionine
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample dataNot Available Recruiting Not Available COVID-19, Long Haul / Long Haul COVID / Post-Acute COVID-19 / Post-acute COVID-19 (PACS), or "Long COVID" Syndrome 1 somestatus stop reason just information to hide
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Liquid Intravenous Cream Vaginal Solution Intravenous Solution, concentrate Intravenous Solution Parenteral Tablet Oral Liquid Oral Emulsion Intravenous 0.468 g Tablet, extended release Oral Capsule Oral Emulsion Intravenous Emulsion Parenteral Emulsion Intravenous 4 g Tablet, sugar coated Oral - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 23.9 mg/mL ALOGPS logP -1.8 ALOGPS logP -2.2 Chemaxon logS -0.8 ALOGPS pKa (Strongest Acidic) 2.53 Chemaxon pKa (Strongest Basic) 9.5 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 3 Chemaxon Hydrogen Donor Count 2 Chemaxon Polar Surface Area 63.32 Å2 Chemaxon Rotatable Bond Count 4 Chemaxon Refractivity 37.59 m3·mol-1 Chemaxon Polarizability 15.61 Å3 Chemaxon Number of Rings 0 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 129.8718456 predictedDarkChem Lite v0.1.0 [M-H]- 129.9262 predictedDeepCCS 1.0 (2019) [M+H]+ 130.7389456 predictedDarkChem Lite v0.1.0 [M+H]+ 132.68901 predictedDeepCCS 1.0 (2019) [M+Na]+ 130.1841456 predictedDarkChem Lite v0.1.0 [M+Na]+ 141.0754 predictedDeepCCS 1.0 (2019)
Drug created at January 17, 2018 22:23 / Updated at October 20, 2021 17:29